Cost-Effectiveness Analysis of Alectinib Compared To Chemotherapy for The Treatment of Treatment-Naïve Patients With Alk Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Greece
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.200
https://www.valueinhealthjournal.com/article/S1098-3015(17)30534-X/fulltext
Title :
Cost-Effectiveness Analysis of Alectinib Compared To Chemotherapy for The Treatment of Treatment-Naïve Patients With Alk Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30534-X&doi=10.1016/j.jval.2017.08.200
First page :
A433
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
184